Put Skin Cancer Risk With Hydrochlorothiazide in Perspective

October 2020

Patients will ask you if they should stop hydrochlorothiazide...based on new labeling that points out increased skin cancer risk.

Growing evidence suggests a link between hydrochlorothiazide and nonmelanoma skin cancer...mostly squamous cell carcinoma.

Photosensitivity with hydrochlorothiazide may play a role.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote